首页> 外文期刊>Indian Journal of Ophthalmology >New superior modified fornix-based twin-site phacotrabeculectomy
【24h】

New superior modified fornix-based twin-site phacotrabeculectomy

机译:新型改良的基于穹ni的改良双位超声小梁切除术

获取原文
获取外文期刊封面目录资料

摘要

Phacotrabeculectomy is the preferred surgical management of coexisting visually significant cataract and moderate to advanced glaucoma. We report the surgical technique of a new modified fornix-based separate-site phacotrabeculectomy, with mitomycin C (MMC) application, in both primary open angle and angle closure glaucoma. In this new separate-site technique, both phaco and filtration are accommodated superiorly, side by side, hence called twin-site. This was achieved in an efficacious and safe manner with sparing of limbal stem cells without compromising safety. It is not only MMC-compatible but also has a low incidence of wound leak. The technique has no adverse consequence on the survival of the bleb, and we achieved complete success in 79.2% and total success in 93.1% in 130 eyes of 117 patients, in the intermediate term. Furthermore, the time taken for this separate-site surgical technique is comparable to published one-site procedures.
机译:并发小梁切除术是并发视觉上显着的白内障和中度至晚期青光眼的首选手术治疗。我们报道了在原发性开角型青光眼和闭角型青光眼中使用丝裂霉素C(MMC)的新型改良型基于穹隆的单点超声乳化小梁切除术的手术技术。在这种新的单独位置技术中,超声乳化和过滤均可以并排放置,因此被称为双位置。这是在不损害安全性的前提下,有效且安全地保留了角膜缘干细胞而实现的。它不仅与MMC兼容,而且伤口渗漏率低。该技术对泡的存活没有不利影响,在中期,我们在117例患者的130眼中获得了79.2%的完全成功率和93.1%的总成功率。此外,这种分部位手术技术所花费的时间与公开的单部位手术相当。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号